Company Filing History:
1 out of 51 
1 out of 2 Years Active: 2025
Title: Christopher James Lord: Innovator in Cancer Treatment
Introduction
Christopher James Lord is a notable inventor based in London, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.
Latest Patents
Lord holds a patent for "Inhibitors of Ataxia-Telangiectasia Mutated and Rad3-related protein kinase (ATR) for use in methods of treating cancer." This invention focuses on ATR inhibitors that are utilized in treating BAF-complex deficient cancers. The patent also outlines methods for identifying ATR inhibitors specifically for BAF complex gene mutant or deficient cancers. Additionally, it provides medical uses and methods related to the treatment of synovial sarcoma using ATR inhibitors.
Career Highlights
Throughout his career, Christopher James Lord has worked with esteemed organizations such as the Institute of Cancer Research and Breast Cancer Now. His work has been pivotal in advancing cancer research and treatment methodologies.
Collaborations
Lord has collaborated with notable colleagues, including Chris Williamson and Samuel Jones, contributing to the collective effort in cancer research and innovation.
Conclusion
Christopher James Lord's contributions to cancer treatment through his patent and career achievements highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cancer therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.